RARITAN, N.J., Oct. 28, 2016 /PRNewswire/ -- Ortho Clinical Diagnostics (Ortho), a global leader of in vitro diagnostics, today announced that the U.S. Food and Drug Administration has cleared its VITROS® Automation Solutions for use with Ortho’s VITROS® Chemistry, Immunodiagnostics and Integrated Systems, allowing U.S. clinical laboratories using VITROS® Automation Solutions to improve results throughout every phase of diagnostic testing, now and into the future. VITROS® Automation Solutions will be available for purchase in the U.S. starting October 2016.
VITROS® Automation Solutions is an open platform both expandable and adaptive that provides laboratory clinicians the flexibility to run and grow their labs in exactly the manner that works best for them, even as needs change over time.
“VITROS® Automation Solutions gives us the flexibility to cope with low and high peak capacity,” said Dr. Giovanni Garozzo, director of the Transfusion Centres of ASP Ragusa, Italy.
“VITROS® Automation Solutions is Ortho’s answer to the limitations of past automation systems,” said Robert Yates, chief operating officer at Ortho. “Through its flexibility, scalability and start-to-finish automation capability, our next-generation VITROS® Automation Solutions platform puts high-volume laboratory clinicians in total control of their facilities.”
Capabilities of VITROS® Automation Solutions’ include:
- Open Connectivity
- Enables labs to connect to third-party analyzers that complement VITROS Automation Solutions in disciplines such as coagulation and hematology, as well as to select immunoassay platforms that broaden menu coverage
- Flexible Data Management using Instrument Manager
- Allows labs to configure solutions that address their specific needs
- Provides necessary flexibility for adaption to a fast-changing environment
- Refrigerated Storage
- Simplifies and automates post-analytical sample processing using this on-line storage module, which allows for up to 14,000 samples to be archived and retrieved for re-testing -- a critical requirement for high-volume laboratories seeking to increase productivity and reduce errors.
The improvement in control has impact across operations, performance and quality. VITROS® Automation Solutions’ Thermo Scientific TCAutomation allows laboratories to define capabilities over time for optimal efficiencies. IMSolutions for VITROS® Automation Solutions delivers fast results, instant access to timely, actionable performance metrics, and minimal disruption with pre-written auto-verification rules. Ortho’s proprietary Intellicheck Technology gives real-time process control that protects the integrity of results. Additionally, with Ortho’s e-Connectivity® Remote Diagnostics Management, instrument performance is continuously tracked, helping to identify specific service needs up to 30 days in advance, and to improve instrument uptime.
Designed to be easily scalable, VITROS® Automation Solutions platform allows for stepwise investment, which lets laboratories grow as their needs do and as new modules become available. It also allows skilled technicians to focus on higher value-added tasks that truly require human interaction. Automation technology also reduces errors and turnaround times. The net effect is a more cost-efficient workplace and improved patient care.
About VITROS
The VITROS Chemistry, Immunodiagnostics and Integrated Systems from Ortho Clinical Diagnostics is a portfolio of products and patented enabling technologies which helps clinical laboratories diagnose, monitor and treat disease. VITROS Products are engineered to help clinical laboratories with organizational, operational and economic challenges.
About Ortho Clinical Diagnostics
Ortho Clinical Diagnostics is a global leader of in vitro diagnostics serving the global clinical laboratory and immunohematology communities. Across hospitals, hospital networks, blood banks, and labs in more than 120 countries, Ortho’s high-quality products and services enable health care professionals to make better-informed treatment decisions. Ortho brings sophisticated testing technologies, automation, information management and interpretation tools to clinical laboratories around the world to help them run more efficiently and effectively and improve patient care. For the immunohematology community, Ortho’s blood typing products help ensure every patient receives blood that is safe, the right type and the right unit. Ortho’s purpose is to improve and save lives with diagnostics, and it does that by reimagining what’s possible. This is what has defined Ortho for more than 75 years, and it’s what drives Ortho forward. For more information, visit www.orthoclinicaldiagnostics.com.
VITROS® Automation Solutions is a trademark of Ortho Clinical Diagnostics.
© Ortho Clinical Diagnostics 2016
Logo - http://photos.prnewswire.com/prnh/20161027/433540LOGO
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/fda-clears-vitros-automation-solutions-from-ortho-clinical-diagnostics-300353418.html
SOURCE Ortho Clinical Diagnostics
